Calima Energy (ASX:CE1) Presentation, FNN Investor Event, October 2019, Sydney

Company Presentations

Calima Energy Limited (ASX:CE1) Managing Director, Alan Stein, presents on results from the 3 well drill program at the Montney project, strategy and recent capital raising, at the FNN Investor Event.

Key points:

  • Founded in 2015 by experienced nuclear medicine executives
  • Develops diagnostic and therapeutic radiopharmaceuticals
  • Specialises in metastatic prostate cancer, renal cell cancer, brain cancer
  • Early revenue generation from prostate cancer imaging product
  • Prostate cancer radionuclide therapy is $2b opportunity
  • Renal cancer patients are often mis-staged, a niche $250m opportunity
  • The treatment of GBM is a $300m market opportunity

For more, watch Managing Director Alan Stein present.